Clinical trial
Preservation and Expansion of T-cell Subsets Following HAART De-intensification…
NCT00491556 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00491556 |
|---|---|
| Title | Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) |
| Official title | Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) in Adolescents With CD4 + T Cells > 350 Cells/mm3 Initiating HAART |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH National Institute of Mental Health (NIMH) International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Early Initiation of Highly Active Anti-Retroviral Therapy, Standard Care |
| Enrollment | 102 |
| Start date | Oct 1, 2007 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Jun 26, 2007 |
| Last update posted | Mar 29, 2017 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: